Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
Ultan McDermott(AstraZeneca (United Kingdom)), Jeffrey Settleman(Harvard University), Jennifer Lamb(Harvard University), Jeff H. Hanke(AstraZeneca (United States)), Raul Raudales(Harvard University), Hensin Tsao(Massachusetts General Hospital), S. Michael Rothenberg(Pfizer (United States)), Nathanael S. Gray(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Heidi Archibald(Harvard University), A. John Iafrate(Peter MacCallum Cancer Centre), Raffaella Sordella(Cold Spring Harbor Laboratory), Lori Dowell(Harvard University), Shyamala Maheswaran(Massachusetts General Hospital), Sreenath V. Sharma(Harvard University), Patricia Greninger(Harvard University), Jeffrey G. Supko(Harvard University), Lisa Drew(AstraZeneca (United States)), Xiaojun Ma(Advanced Cell Diagnostics (United States)), Diana Lee, Angela Tam(Canada's Michael Smith Genome Sciences Centre), Ching Ni Njauw(Massachusetts General Hospital), Clara Montagut(Hospital Del Mar), Lindsey E. Ulkus(Harvard University), Mark G. Erlander
Cited by 358